IPO
Option Therapeutics Inc.
Filed with the SEC to go public on Jan 26, 2026. Newest amendment Mar 16, 2026.
Terms
| Price range | US$10.00 to US$12.00 a share | |
| Shares offered | 1,818,182 shares of common stock | |
| Offering size | US$18.2 million to US$21.8 million | Shares offered times the price range, worked out by 6ix |
| Underwriters' option | Up to 272,727 more shares | |
| Listing | OPTN on NYSE American | Intends to list |
| Underwriter | ThinkEquity |
From the cover of the amended prospectus (S-1/A) filed Mar 16, 2026
Steps
| Draft sent to the SEC in confidence | Sep 5, 2025 |
| Filed publicly | Jan 26, 2026 |
| Amended once | Mar 16, 2026 |
| Shares registered with an exchange | Not yet |
| Declared effective by the SEC | Not yet |
| Final prospectus, with the price | Not yet |
Filings
- Mar 16, 2026 S-1/A · Registration statement, amended
- Jan 26, 2026 S-1 · Registration statement
- Dec 15, 2025 DRS/A · Draft registration statement, amended
- Sep 5, 2025 DRS · Draft registration statement